HOME >> BIOLOGY >> NEWS
A novel, safer strategy for regulating gene expression

Researchers at Children's Hospital Boston and Harvard Medical School have created a novel, elegant, and safer system for controlling gene expression turning genes on and off as needed that involves an intervention as simple as giving a drug. Potentially, with this technique, a gene could even be activated by natural conditions in the body for example, in a diabetic patient, a rise in glucose concentration would automatically turn on the gene responsible for insulin production.

The system, described in a proof-of-principle paper in the Sept. 23 edition of the journal Nature, is simpler than current methods of gene regulation, and the technology exists to make it work with virtually any drug, making it suitable for a broad range of therapeutic and research applications.

The technique involves inserting a special DNA sequence into a patient's own genes, or into a gene introduced by gene therapy. This sequence encodes a ribozyme, a sequence of RNA that has the unique ability to spontaneously cut itself in half. The ribozyme becomes part of the gene's messenger RNA (mRNA), the template that carries instructions for making the protein encoded by that gene. When the ribozyme cuts itself in half, the mRNA is cut in half, too disabling it and, in effect, turning off the gene. Inhibiting ribozyme breakage, which can be done with various drugs, leaves the mRNA intact; this allows the gene to turn "on" and make the desired protein such as a hormone or growth factor needed by the body.

"Perhaps the most exciting aspect of the new work is that, in conjunction with other technologies, we will likely be able to 'tailor' gene regulation systems to respond to any drug or chemical," says Dr. Richard Mulligan, director of gene therapy research at Children's Hospital Boston and director of the Harvard Gene Therapy Initiative. "Ultimately, the system should also enable the 'release' of a therapeutically useful protein in response to changing concentrat
'"/>

Contact: Aaron Patnode
aaron.patnode@childrens.harvard.edu
617-355-6420
Children's Hospital Boston
22-Sep-2004


Page: 1 2 3

Related biology news :

1. Childrens Hospital Boston receives more than $10 million to help make smallpox vaccine safer
2. The search for a safer smallpox vaccine: New data released on promising candidate
3. NIH awards $20.7 million to make smallpox vaccine safer
4. EUREKA project finds safer way to destroy BSE waste
5. Physiologists findings make fishing tournaments safer for fish!
6. NHGRI study may help scientists develop safer methods for gene therapy
7. Making a safer anthrax vaccine using spinach
8. HHS announces contracts to develop safer smallpox vaccines
9. UT Southwestern researchers developing new procedures to make bone-marrow transplants safer
10. Medical devices safe, but could be safer with better regulation
11. New study promises safer hormone replacement therapy

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/23/2019)... ... , ... NanoFUSE is pleased to announce the ... spine and orthopedic use. Bioactive glass is a calcium phosphate coated silica that ... orthopedics for over 30 years and now NanoFUSE Biologics has used advanced research ...
(Date:7/19/2019)... ... July 19, 2019 , ... ... and Crystalline States – Insights from Synchrotron X-ray Pair Distribution (SXPDF) Studies”. The ... with Chris Benmore of Argonne National Laboratory and Gabriel de Araujo of the ...
(Date:7/17/2019)... Pa. (PRWEB) , ... July 15, 2019 , ... ... of computational science expertise exclusively for Life Sciences and Healthcare companies, announces the ... provide critical advisory services and strategic direction to start-up and emerging bio-pharma companies ...
Breaking Biology News(10 mins):
(Date:6/11/2019)... Fla. (PRWEB) , ... June 10, 2019 , ... ... in science and technology in an upcoming episode, scheduled to broadcast 4Q/2019. Check ... the Eppendorf Group) and will educate viewers about how its technology facilitates laboratories ...
(Date:6/11/2019)... POWAY, Calif. (PRWEB) , ... June 11, 2019 ... ... parent company of Personalized Stem Cells Inc. (PSC) , has announced that ... of Public Health, Food and Drug Branch for manufacturing. This is an ...
(Date:5/31/2019)... ... May 29, 2019 , ... For many years, the primary forms of cancer ... breakthrough therapies. Advances in immuno-oncology have led to the advent of Chimeric Antigen Receptor ... T cell receptors known as “CARs”. The CAR enables the final product to produce ...
(Date:5/31/2019)... ... May 30, 2019 , ... Object ... announce the strategic acquisition of Metabiologics, Inc., a globally recognized leader in the ... ownership and commercialization rights to a full spectrum of botulinum neurotoxins, as well ...
Breaking Biology Technology:
Cached News: